Company profile
Vaso Corporation
OTC: VASO · Healthcare · Medical - Healthcare Information Services
#358 of 1,418 Healthcare companies by revenue46th-percentile growth
EA Score
68BFH 75DQ 57GM 64SS 75
v0.1 · 65/100 weight · provisional
↑ growth stability, listing tenure · ↓ filing timeliness, revenue growth (YoY)
Methodology →Revenue TTM
$89.0M
Rev growth YoY (TTM)
+1.7%
Net income (FY)
$1.6M
Employees
282
as of 2026-08-20
Market cap
$51.0M
as of 2026-08-20
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$89.1M$89.1M2025
Net income$1.6M$1.6M2025
Operating income-$2.9M-$2.9M2025
Total assets$88.3M$88.3M2025
Equity$29.4M$29.4M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2021
By product
Information Technology57%
Professional Sales Service39%
Equipment4%
By geography
Domestic (United States)97%
Non-Domestic (Foreign)3%
The read
What is Vaso Corporation’s revenue?
Vaso Corporation booked $89.1M in FY2025 revenue, growing 2.7% year over year — about the middle of the pack among Healthcare companies we track, at a 1.8% net margin.
Peers · Healthcare
BioLife Solutions, Inc.74BSIGA Technologies, Inc.73BPulmonx Corporation57CCeriBell, Inc.49DBiodesix, Inc.57CCytokinetics, Incorporated59CNeighbors
Nassau →Key facts
CEOJun Ma
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersPlainview, NY
ExchangeOTC: VASO
Employees282
IPO date1995-08-18
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.